Author response for "Efficacy and Safety of Janagliflozin as Add‐on Therapy to Metformin in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Double‐blind, Placebo‐controlled, Phase 3 Trial"
crossref（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined